abrdn plc Has $55.19 Million Stock Holdings in STERIS plc (NYSE:STE)

abrdn plc boosted its holdings in shares of STERIS plc (NYSE:STE) by 27.0% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 251,044 shares of the medical equipment provider’s stock after acquiring an additional 53,444 shares during the period. abrdn plc owned 0.25% of STERIS worth $55,192,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in STE. Yousif Capital Management LLC boosted its position in shares of STERIS by 0.7% during the first quarter. Yousif Capital Management LLC now owns 15,327 shares of the medical equipment provider’s stock worth $3,706,000 after purchasing an additional 106 shares in the last quarter. Vontobel Holding Ltd. boosted its position in shares of STERIS by 25.6% during the first quarter. Vontobel Holding Ltd. now owns 1,919 shares of the medical equipment provider’s stock worth $471,000 after purchasing an additional 391 shares in the last quarter. Blair William & Co. IL boosted its position in shares of STERIS by 8.1% during the first quarter. Blair William & Co. IL now owns 13,523 shares of the medical equipment provider’s stock worth $3,269,000 after purchasing an additional 1,010 shares in the last quarter. Cetera Investment Advisers boosted its position in shares of STERIS by 24.4% during the first quarter. Cetera Investment Advisers now owns 2,345 shares of the medical equipment provider’s stock worth $567,000 after purchasing an additional 460 shares in the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of STERIS by 1.3% during the first quarter. Vanguard Group Inc. now owns 11,525,769 shares of the medical equipment provider’s stock worth $2,786,586,000 after purchasing an additional 143,253 shares in the last quarter. 94.69% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on STE. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Friday, April 12th. Stephens reaffirmed an “overweight” rating and issued a $250.00 price objective on shares of STERIS in a research report on Friday, February 9th. JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research report on Thursday, February 8th. TheStreet raised shares of STERIS from a “c+” rating to a “b” rating in a research report on Wednesday, February 7th. Finally, KeyCorp assumed coverage on shares of STERIS in a research report on Tuesday, February 6th. They issued an “overweight” rating and a $253.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $239.60.

STERIS Trading Down 0.6 %

Shares of NYSE:STE opened at $199.51 on Monday. The company’s 50-day moving average price is $223.71 and its two-hundred day moving average price is $217.44. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.43 and a quick ratio of 1.49. STERIS plc has a one year low of $180.54 and a one year high of $254.00. The stock has a market capitalization of $19.71 billion, a PE ratio of 34.94 and a beta of 0.79.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, topping the consensus estimate of $2.17 by $0.05. The company had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.35 billion. STERIS had a net margin of 10.48% and a return on equity of 13.67%. STERIS’s revenue for the quarter was up 14.8% compared to the same quarter last year. During the same period in the previous year, the business earned $2.02 EPS. On average, equities analysts forecast that STERIS plc will post 8.67 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 22nd. Stockholders of record on Friday, February 23rd were paid a dividend of $0.52 per share. The ex-dividend date was Thursday, February 22nd. This represents a $2.08 annualized dividend and a dividend yield of 1.04%. STERIS’s dividend payout ratio is presently 36.43%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.